⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
MLTX News
MoonLake Immunotherapeutics Class A Ordinary Shares
Securities Lawsuit Alert: MoonLake Immunotherapeutics (MLTX) Investors – Contact Levi & Korsinsky Before December 15, 2025
accessnewswire.com
MLTX
Qiming Venture Partners Donates HK$3 Million to Tai Po Wang Fuk Court Aid Fund for Post-Fire Recovery
prnewswire.com
XOM
MSFT
GOOG
AMZN
NVDA
TSLA
META
BABA
JD
PDD
NTES
BILI
ZNH
RRBT
HSAI
UBOT
WRDE
HSTR
INST
UNIS
GEL
TIGR
ZLAB
CNBC
SRCH
APM
SMY
AMDX
SCNL
ASPB
YXT
INSM
MLTX
LNV
STEF
Pomerantz LLP Issues Important Reminder to Shareholders in MoonLake Immunotherapeutics of Class Action Lawsuit – MLTX
accessnewswire.com
MLTX
SHAREHOLDER ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of MoonLake Immunotherapeutics
globenewswire.com
MLTX
MLTX STOCK: Lose Money on Your MoonLake Immunotherapeutics Investment? Contact BFA Law about the Pending Securities Class Action before December 15 Deadline
globenewswire.com
MLTX
Pomerantz LLP Issues Important Reminder to Shareholders in MoonLake Immunotherapeutics of Class Action Filing – MLTX
accessnewswire.com
MLTX
MoonLake Immunotherapeutics' (MLTX) Stock Crashes 90%, Triggers Lawsuit After Reported Phase 3 Trial Data for Sole Drug Candidate -- Hagens Berman
prnewswire.com
MLTX
MLTX INVESTOR REMINDER: MoonLake Immunotherapeutics Investors are Encouraged to Act in Securities Class Action - Contact BFA Law by December 15 Deadline
accessnewswire.com
MLTX
UPCOMING DEADLINE: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of MoonLake Immunotherapeutics
newsfilecorp.com
MLTX
Class Action Lawsuit Filed Against MoonLake Immunotherapeutics (MLTX) - Recover Losses - Contact Levi & Korsinsky Before December 15, 2025
accessnewswire.com
MLTX